Stalexport Autostrady SA (STX)
Warsaw Stock Exchange · Poland · prices in PLN · close of 27 Oct 2026
Key indicators
| Last close | PLN 1.982 |
|---|---|
| 52-week range | 1.700 – 3.455 |
| Return, 1 month / 3 months | +13.1% / +6.8% |
| Return, 1 year / 3 years | −9.1% / +43.1% |
| Trend | Below its 200-day average |
| RSI (14) | 71 |
| Volatility (1 year) | 31.2% |
| Worst drawdown (1 year) | -33.6% |
| Average daily value traded | 0.57M PLN |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Stalexport Autostrady is a Polish company based in the Katowice area that operates toll motorway infrastructure. Its main activity is managing the concession for a stretch of the A-four motorway linking Katowice and Krakow, where it handles maintenance, road operations and toll collection. Its customers are the drivers and transport firms that use the route, and its revenue comes from motorway tolls. The company also has interests in related road infrastructure and construction services through its group.
On this site Stalexport Autostrady SA appears as a stock on the Warsaw Stock Exchange (Poland), code STX, with prices in Polish zloty (PLN). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Stalexport Autostrady SA (STX) trades on the Warsaw Stock Exchange in Poland. It last closed at PLN 1.982 on 27 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 273 of 580 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 9.1% and over the last three months it rose 6.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Warsaw Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 31 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -1.1% | ||
| From 52-week high | -42.5% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 6.8% | ||
| 6-month return | -5.7% | ||
| 12-month return, skipping the last month | -19.6% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -33.6% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 0.57M PLN | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +6.4% |
|---|---|
| 1 month | +13.1% |
| 3 months | +6.8% |
| 6 months | −5.7% |
| 1 year | −9.1% |
| 3 years | +43.1% |
| 5 years | +6.1% |
Signals
| 50-day / 200-day average | 1.798 / 2.005 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.048 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Jun 2026 | PLN 0.7300 |
| 16 Apr 2025 | PLN 0.6300 |
| 18 Apr 2024 | PLN 0.4500 |
| 12 Apr 2023 | PLN 0.2000 |
| 12 Apr 2022 | PLN 0.2400 |
| 8 Apr 2021 | PLN 0.6400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Warsaw Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.